BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes-Reference-Cited by-同舟云学术

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes

Published:2013-10 Issue:10 Volume:2 Page:e26615
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Cooper Zachary A,Frederick Dennie T,Juneja Vikram R,Sullivan Ryan J,Lawrence Donald P,Piris Adriano,Sharpe Arlene H,Fisher David E,Flaherty Keith T,Wargo Jennifer A

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/onci.26615

Reference32 articles.

1. Mutation-driven drug development in melanoma

2. Mutations of the BRAF gene in human cancer

3. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

4. Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

5. Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma;Blood Cancer Journal;2023-12-14

2. T‐cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood;Cancer Science;2023-11-14

3. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4⁺ T cells through regulating type 2 conventional dendritic cells;Theranostics;2023

4. Lacking Overall IMspiration for Triplet Therapy in Melanoma? A Review of the Interim Analysis of IMspire150;Journal of Cutaneous Oncology;2023

5. Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma;International Journal of Molecular Sciences;2022-10-27